Octreotide prevents l-asparaginase-induced pancreatic injury in rats

Experimental Hematology

Volumn 36, Issue 2, 2008, Pages 172-180

  Suzuki, Mitsuyoshi ^a   Shimizu, Toshiaki ^a   Kudo, Takahiro ^a   Shoji, Hiromichi ^a   Ohtsuka, Yoshikazu ^a   Yamashiro, Yuichiro ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLASE; APROTININ; ASPARAGINASE; OCTREOTIDE; PANCREAS ENZYME; TRIACYLGLYCEROL LIPASE; TRYPSIN;

ACINAR CELL; ACUTE LYMPHOBLASTIC LEUKEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CHEMOTHERAPY; CONTROLLED STUDY; ESCHERICHIA COLI; HISTOLOGY; MALE; NONHUMAN; PANCREAS INJURY; PANCREATITIS; PRIORITY JOURNAL; RAT; TREATMENT OUTCOME;

AMYLASES; ANIMALS; ANTINEOPLASTIC AGENTS; ASPARAGINASE; DOSE-RESPONSE RELATIONSHIP, DRUG; ESCHERICHIA COLI PROTEINS; GASTROINTESTINAL AGENTS; MALE; OCTREOTIDE; PANCREAS; PANCREATITIS; RATS; RATS, WISTAR; TRYPSIN; TRYPSIN INHIBITORS;

ESCHERICHIA COLI; RATTUS;

EID: 38149032567     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2007.09.005     Document Type: Article

References (50)

1. Ohnuma T., Holland J.F., Freeman A., and Sinks L.F. Biochemical and pharmacological studies with asparaginase in man. Cancer Res 30 (1970) 2297-2305
2. Avramis V.I., and Panosyan E.H. Pharmacokinetic/pharmacodynamic relationships of asparaginase formulations: the past, the present and recommendations for the future. Clin Pharmacokinet 44 (2005) 367-393
3. Richards N.G., and Kilberg M.S. Asparagine synthetase chemotherapy. Annu Rev Biochem 75 (2006) 629-654
4. Muller H.J., and Boos J. Use of L-asparaginase in childhood ALL. Crit Rev Oncol Hematol 28 (1998) 97-113
5. McLean R., Martin S., and Lam-Po-Tang P.R. Fatal case of L-asparaginase induced pancreatitis. Lancet 2 (1982) 1401-1402
6. Sahu S., Saika S., Pai S.K., and Advani S.H. L-asparaginase (Leunase) induced pancreatitis in childhood acute lymphoblastic leukemia. Pediatr Hematol Oncol 15 (1998) 533-538
7. Alvarez O.A., and Zimmerman G. Pegaspargase-induced pancreatitis. Med Pediatr Oncol 34 (2000) 200-205
8. Knoderer H.M., Robarge J., and Flockhart D.A. Predicting asparaginase-associated pancreatitis. Pediatr Blood Cancer 9 (2007) 634-639
9. Pless J., Bauer W., Briner U., et al. Chemistry and pharmacology of SMS 201-995, a long-acting octapeptide analogue of somatostatin. Scand J Gastroenterol Suppl 119 (1986) 54-64
10. Toro M.J., Birnbaumer L., Redon M.C., and Montoya E. Mechanism of action of somatostatin. Horm Res 29 (1988) 59-64
11. Katz M.D., and Erstad B.L. Octreotide, a new somatostatin analogue. Clin Pharm 8 (1989) 255-273
12. Greenberg R., Haddad R., Kashtan H., and Kaplan O. The effects of somatostatin and octreotide on experimental and human acute pancreatitis. J Lab Clin Med 135 (2000) 112-121
13. Li-Ling J., and Irving M. Somatostatin and octreotide in the prevention of postoperative pancreatic complications and the treatment of enterocutaneous pancreatic fistulas: a systematic review of randomized controlled trials. Br J Surg 88 (2001) 190-199
14. Lowy A.M., Lee J.E., Pisters P.W., et al. Prospective, randomized trial of octreotide to prevent pancreatic fistula after pancreaticoduodenectomy for malignant disease. Ann Surg 226 (1997) 632-641
15. Bonatti H., Tabarelli W., Berger N., et al. Successful management of a proximal pancreatic duct fistula following pancreatic transplantation. Dig Dis Sci 51 (2006) 2026-2030
16. Li Z.S., Pan X., Zhang W.J., et al. Effect of octreotide administration in the prophylaxis of post-ERCP pancreatitis and hyperamylasemia: A multicenter, placebo-controlled, randomized clinical trial. Am J Gastroenterol 102 (2007) 46-51
17. Sternlieb J.M., Aronchick C.A., Retig J.N., et al. A multicenter, randomized, controlled trial to evaluate the effect of prophylactic octreotide on ERCP-induced pancreatitis. Am J Gastroenterol 87 (1992) 1561-1566
18. Binmoeller K.F., Harris A.G., Dumas R., Grimaldi C., and Delmont J.P. Does the somatostatin analogue octreotide protect against ERCP induced pancreatitis?. Gut 33 (1992) 1129-1133
19. Garrington T., Bensard D., Ingram J.D., and Silliman C.C. Successful management with octreotide of a child with L-asparaginase induced hemorrhagic pancreatitis. Med Pediatr Oncol 30 (1998) 106-109
20. Cheung Y.F., Lee C.W., Chan C.F., Chan K.L., Lau Y.L., and Yeung C.Y. Somatostatin therapy in L-asparaginase-induced pancreatitis. Med Pediatr Oncol 22 (1994) 421-424
21. Gentili D., Zucchetti M., Conter V., Masera G., and D'Incalci M. Determination of L-asparagine in biological samples in the presence of L-asparaginase. J Chromatogr B Biomed Appl 657 (1994) 47-52
22. Deyl Z., Hyanek J., and Horakova M. Profiling of amino acids in body fluids and tissues by means of liquid chromatography. J Chromatogr 379 (1986) 177-250
23. Lorentz K. Approved recommendation on IFCC methods for the measurement of catalytic concentration of enzymes. Part 9. IFCC method for alpha-amylase (1,4-alpha-D-glucan 4-glucanohydrolase, EC 3.2.1.1). International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). Committee on Enzymes. Clin Chem Lab Med 36 (1998) 185-203
24. Panteghini M., Bonora R., and Pagani F. Measurement of pancreatic lipase activity in serum by a kinetic colorimetric assay using a new chromogenic substrate. Ann Clin Biochem 38 (2001) 365-370
25. Malvano R., Marchisio M., Massaglia A., et al. Radioimmunoassay of trypsin-like substance in human serum. Scand J Gastroenterol Suppl 62 (1980) 3-10
26. Kitahara T., Takatsuka Y., Fujimoto K.I., Tanaka S., Ogawa M., and Kosaki G. Radioimmunoassay for human pancreatic secretory trypsin inhibitor: measurement of serum pancreatic secretory trypsin inhibitor in normal subjects and subjects with pancreatic diseases. Clin Chim Acta 103 (1980) 135-143
27. Dolowy W.C., Henson D., Cornet J., and Sellin H. Toxic and antineoplastic effects of L-asparaginase. Study of mice with lymphoma and normal monkeys and report on a child with leukemia. Cancer 19 (1966) 1813-1819
28. Hill J.M., Roberts J., Loeb E., Khan A., MacLellan A., and Hill R.W. L-asparaginase therapy for leukemia and other malignant neoplasms. Remission in human leukemia. JAMA 202 (1967) 882-888
29. Ortega J.A., Nesbit Jr. M.E., Donaldson M.H., et al. L-Asparaginase, vincristine, and prednisone for induction of first remission in acute lymphocytic leukemia. Cancer Res 37 (1977) 535-540
30. Pui C.H., Sandlund J.T., Pei D., et al. Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children's Research Hospital. Blood 104 (2004) 2690-2696
31. Duval M., Suciu S., Ferster A., et al. Comparison of Escherichia coli-asparaginase with Erwinia-asparaginase in the treatment of childhood lymphoid malignancies: results of a randomized European Organisation for Research and Treatment of Cancer-Children's Leukemia Group phase 3 trial. Blood 99 (2002) 2734-2739
32. Moghrabi A., Levy D.E., Asselin B., et al. Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia. Blood 109 (2007) 896-904
33. Sallan S.E. Myths and lessons from adult/pediatric interface in acute lymphoblastic leukemia. American Society of Hematology Education Program Book (2006), John Wiley & Sons, Inc, NY p.128-132
34. DeAngelo D.J., Silverman L.B., Couban S., et al. A multicenter phase II study using a dose intensified pediatric regimen in adults with untreated acute lymphoblastic leukemia. [abstract]. Blood 108 (2006) (ASH Annual Meeting Abstracts):Abstract 1858
35. Storring J.M., Brandwein J., Gupta V., et al. Treatment of adult acute lymphoblastic leukemia (ALL) with a modified DFCI pediatric regimen-The Princess Margaret experience. [abstract]. Blood 108 (2006) (ASH Annual Meeting Abstracts):Abstract 1875
36. Boquist L. Morphologic effects of ethionine on the pancreas of the Chinese hamster. A light and electron microscopic study of degenerative changes. Acta Pathol Microbiol Scand 76 (1969) 91-105
37. Saito I., Hashimoto S., Saluja A., Steer M.L., and Meldolesi J. Intracellular transport of pancreatic zymogens during caerulein supramaximal stimulation. Am J Physiol 253 (1987) G517-G526
38. Thrower E.C., Diaz de Villalvilla A.P., Kolodecik T.R., and Gorelick F.S. Zymogen activation in a reconstituted pancreatic acinar cell system. Am J Physiol Gastrointest Liver Physiol 290 (2006) G894-G902
39. Koike H., Steer M.L., and Meldolesi J. Pancreatic effects of ethionine: blockade of exocytosis and appearance of crinophagy and autophagy precede cellular necrosis. Am J Physiol 242 (1982) G297-G307
40. Putter J. Pharmacokinetic behavior of L-asparaginase in men and in animals. Recent Results Cancer Res 33 (1970) 64-74
41. Shimizu T., Yamashiro Y., Igarashi J., Fujita H., and Ishimoto K. Increased serum trypsin and elastase-1 levels in patients undergoing L-asparaginase therapy. Eur J Pediatr 157 (1998) 561-563
42. Kruse P., Hage E., and Lasson A. Proteases and protease inhibitors in taurocholate-induced acute pancreatitis in rats. Int J Pancreatol 25 (1999) 113-121
43. Hernandez-Espinosa D., Minano A., Martinez C., et al. L-asparaginase-induced antithrombin type I deficiency: implications for conformational diseases. Am J Pathol 169 (2006) 142-153
44. Keiles S., and Kammesheidt A. Identification of CFTR, PRSS1, and SPINK1 mutations in 381 patients with pancreatitis. Pancreas 33 (2006) 221-227
45. Sobczynska-Tomaszewska A., Bak D., Oralewska B., et al. Analysis of CFTR, SPINK1, PRSS1 and AAT mutations in children with acute or chronic pancreatitis. J Pediatr Gastroenterol Nutr 43 (2006) 299-306
46. Larson R.A., Fretzin M.H., Dodge R.K., and Schiffer C.A. Hypersensitivity reactions to L-asparaginase do not impact on the remission duration of adults with acute lymphoblastic leukemia. Leukemia 12 (1998) 660-665
47. Woo M.H., Hak L.J., Storm M.C., et al. Hypersensitivity or development of antibodies to asparaginase does not impact treatment outcome of childhood acute lymphoblastic leukemia. J Clin Oncol 18 (2000) 1525-1532
48. Top P.C., Tissing W.J., Kuiper J.W., Pieters R., and van Eijck C.H. L-asparaginase-induced severe necrotizing pancreatitis successfully treated with percutaneous drainage. Pediatr Blood Cancer 44 (2005) 95-97
49. Uhl W., Buchler M.W., Malfertheiner P., Beger H.G., Adler G., and Gaus W. A randomised, double blind, multicentre trial of octreotide in moderate to severe acute pancreatitis. Gut 45 (1999) 97-104
50. Gong Z., Yuan Y., Lou K., Tu S., Zhai Z., and Xu J. Mechanisms of Chinese herb emodin and somatostatin analogs on pancreatic regeneration in acute pancreatitis in rats. Pancreas 25 (2002) 154-160